Psychosis Associated With Alzheimer's Disease research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
This study is testing a new medicine, KarXT, for people aged 55-90 who have Alzheimer's disease and also experience psychosis (like seeing or hearing things that aren't there, or having strong untrue beliefs). It aims to see if KarXT can help reduce these symptoms and is safe to use.
United States · Belgium · Canada - recruitingPHASE3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
This study is looking into a new medication called KarXT for people with memory problems like Alzheimer's who also experience psychosis. It compares KarXT to a dummy pill to see if it can prevent these symptoms from returning and if it's safe to use.
United States · Bulgaria · Croatia - recruitingPHASE3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
This study looks at the long-term safety of a new medicine, KarXT, for people with changes in their thoughts and feelings due to Alzheimer's disease. Participants have already taken part in similar studies and will continue to be monitored for about a year.
United States · Argentina · Belgium